Literature DB >> 29417590

Association between intimate partner violence during pregnancy and maternal pregnancy complications among recently delivered women in Bangladesh.

Jannatul Ferdos1, Md Mosfequr Rahman1, Syeda S Jesmin2, Md Aminur Rahman1, Toshiyuki Sasagawa3.   

Abstract

Intimate partner violence (IPV), an actual or threatened physical, sexual, or psychological abuse by a current or former partner or spouse, is a common global public health issue. Understanding both the prevalence of IPV during pregnancy and its potential impact on the health of pregnant women is important for the development and implementation of interventions to prevent maternal morbidity and mortality. The purpose of this study was to explore the association between maternal experiences of IPV during pregnancy and pregnancy complications. A health-facility-based cross-sectional study was conducted from July 2015 to April 2016 among 400 randomly selected women who were admitted to the postnatal wards of Rajshahi Medical College Hospital for delivery. Data were collected through face-to-face interviews using a structured questionnaire. Multivariable logistic regressions were performed to assess relationships between variables of interest after controlling for potential confounders. Results indicated that 39.0% of women reported physical IPV and 26.3% of women reported sexual IPV during pregnancy. Additionally, 69.5% of women experienced medical complications (MCs); of this group, 44.3% experienced obstetric complications (OCs) and 79.3% experienced any pregnancy complication (AC) during their last pregnancy. The experience of physical IPV during pregnancy was significantly associated with the experience of MCs (adjusted odds ratio (AOR): 2.05, 95% confidence interval (CI): 1.15-4.01), OCs (AOR: 4.23, 95% CI: 2.01-7.12) and AC (AOR: 5.26, 95% CI: 2.98-10.52). Women who experienced sexual IPV during pregnancy were also at increased risk of suffering from any MC, any OC, and AC. Maternal experience of IPV during pregnancy is positively associated with pregnancy complications. Preventing IPV directed at pregnant women might reduce maternal morbidity and mortality in Bangladesh.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Bangladesh; intimate partner violence; medical complications; obstetric complications; pregnancy complications

Mesh:

Year:  2018        PMID: 29417590     DOI: 10.1002/ab.21752

Source DB:  PubMed          Journal:  Aggress Behav        ISSN: 0096-140X            Impact factor:   2.917


  6 in total

1.  Computerized intervention for reducing intimate partner victimization for perinatal women seeking mental health treatment: A multisite randomized clinical trial protocol.

Authors:  Dawn M Johnson; Golfo Tzilos Wernette; Ted R Miller; Maria Muzik; Christina A Raker; Caron Zlotnick
Journal:  Contemp Clin Trials       Date:  2020-04-17       Impact factor: 2.226

2.  Prevalence and Associated Factors of Intimate Partner Violence During Pregnancy in Eastern Ethiopia.

Authors:  Wondimye Ashenafi; Bezatu Mengistie; Gudina Egata; Yemane Berhane
Journal:  Int J Womens Health       Date:  2020-05-05

3.  Intimate partner violence (IPV) with miscarriages, stillbirths and abortions: Identifying vulnerable households for women in Bangladesh.

Authors:  Awan Afiaz; Raaj Kishore Biswas; Raisa Shamma; Nurjahan Ananna
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

4.  He hurts her womb: Physical-sexual violence and pregnancy complications among women in Afghanistan.

Authors:  Mostafizur Rahman; Priom Saha; Nahida Anwar; Afnan Hossain
Journal:  Health Promot Perspect       Date:  2021-12-19

5.  Spousal violence against women and its consequences on pregnancy outcomes and reproductive health of women in India.

Authors:  Mahadev Bramhankar; R S Reshmi
Journal:  BMC Womens Health       Date:  2021-11-01       Impact factor: 2.809

6.  Exploring the association between adverse maternal circumstances and low birth weight in neonates: a nationwide population-based study in Bangladesh.

Authors:  Md Mostaured Ali Khan; Md Golam Mustagir; Md Rafiqul Islam; Md Sharif Kaikobad; Hafiz Ta Khan
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.